An XL-ent Value?

Recs

0

With the NFL season under way, football fanatics have begun to follow their favorite teams with a passion. I may not be much of a football fan, but I do like to root for the underdog -- both in sports and investing. XL Capital (NYSE: XL), the victim of more than a few stock market sacks lately, definitely fits the bill.

Shares of XL, a leading provider of insurance and reinsurance, have fumbled nearly 20% since peaking last December, and are currently trading near their 52-week low. Investors have been leery of XL's stock because the company had to increase its reserves for its North American reinsurance operations. That wreaked havoc on XL's second-quarter earnings, and just when it appeared as if things couldn't get worse for XL, Hurricane Katrina showed up.

The recent tragedy sent investors punting insurance and reinsurance stocks, and with good reason; the industry could lose anywhere from $25 to $60 billion. Investors are clearly nervous. Last year's Florida hurricanes produced nearly $23 billion in claims, which severely hampered third-quarter profits for major insurers like St. PaulTravelers (NYSE: STA) and Allstate (NYSE: ALL). XL's net losses from Katrina are estimated to be around 1.75% of the disaster's insured total; however, the company still expects to report an operating profit in the third quarter.

Is there value in XL? Last quarter's earnings offered plenty to cheer about. Total revenues rose 30%, and XL achieved a record $55.95 in book value per ordinary share. The company appears to be fairly valued, since its price-to-book ratio is in line with comparable firms, and its price-to-cash-flow ratio is substantially better than its competitors'.

Will additional catastrophic events or unexpected reserve charges continue to plague the insurance industry? No one knows for sure. But with a forward P/E of less than 7, it may be riskier not to invest in XL.

Read more, at your own risk:

Fool contributor M.D. Mitchell is down the street at the local junkyard looking for some good trash. He will read his email as soon as he gets back. At the time of publication, he held no financial position in the companies mentioned above.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 496170, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:55:17 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
ALL $29.51 Up +0.58 +2.00%
The Allstate Corp CAPS Rating: ***
XL $17.94 Up +0.72 +4.18%
XL Capital Ltd. CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!